Determining the effect of sodium levels of dialysis fluid on the levels of calcium, phosphorus and parathyroid hormone in patients undergoing chronic hemodialysis

Comparison of the effect of low and normal levels of sodium in the dialysis fluid on the levels of calcium, phosphorus and parathyroid hormone in patients undergoing chronic hemodialysis

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231217060445N1

Enrollment

Registered

2023-12-30

Start date

2024-01-21

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients undergoing chronic hemodialysis.

Interventions

Intervention 1: Intervention group: Intervention group: the group that will undergo hemodialysis with a sodium solution of 135 mEq/L. Intervention 2: Control group: the group that will undergo hemodi

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Chronic hemodialysis patients aged 18 to 60 years

Exclusion criteria

Exclusion criteria: The presence of any uncontrolled underlying disease (such as pheochromocytoma or other cardio-pulmonary and liver diseases) Presence of active infection Occurrence of frequent muscle cramps that cannot be found due to low sodium. Patient's sodium is less than 130 mEq/L Systolic or diastolic blood pressure drop of more than 20 mm Hg compared to the patient's baseline pressure.

Design outcomes

Primary

Measure	Time frame
Calcium. Timepoint: Before starting the study, one and three months after dialysis. Method of measurement: blood test.;Phosphorus. Timepoint: Before starting the study, one and three months after dialysis. Method of measurement: Blood test.;Parathyroid hormone. Timepoint: Before starting the study, one and three months after dialysis. Method of measurement: Blood test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactLadan Mirzaei

Ahvaz University of Medical Sciences

dr.l.mirzaei@gmail.com+98 61 3337 8628

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026